Cancel
Dirk Brockstedt, Ph.D.
Chief Scientific Officer
@
Rapt Therapeutics
2suln@y2xl.7s1
Sign up to see email
Known information
- Joined RAPT Therapeutics in January 2018
- Brings over 20 years of experience through all stages of discovery, translational and clinical development
- Has a deep knowledge of immunology and the tumor microenvironment
- Previously served as Executive Vice President of Research and Development at Aduro Biotech
- Held positions of increasing responsibility within the immunology department of Cerus Corporation, most recently serving as Director of Immunology
- Worked as a scientist at Aventis in the immunotherapy and anti-angiogenesis group, developing novel therapies against cancer
- Holds an M.S. in Microbiology from the University of Kiel
- Earned a Ph.D. from the University of Kiel, with graduate work performed at Stanford University
- Was a post-doctoral fellow at the Stanford School of Medicine in the Department of Pathology
- Co-authored over 50 scientific papers
- Is a named inventor on seven issued patents and several pending applications
About Rapt Therapeutics
Rapt Therapeutics, headquartered in South San Francisco, develops oral therapies for inflammatory diseases and cancer, focusing on modulating the immune system through its proprietary drug discovery engine.
Report inaccurate information
